These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 27671228)
1. Neuroprotective effects of fingolimod in mouse models of Parkinson's disease. Zhao P; Yang X; Yang L; Li M; Wood K; Liu Q; Zhu X FASEB J; 2017 Jan; 31(1):172-179. PubMed ID: 27671228 [TBL] [Abstract][Full Text] [Related]
2. Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease. Rajan S; Sood A; Jain R; Kamatham PT; Khatri DK Neurosci Lett; 2024 Jan; 820():137596. PubMed ID: 38101611 [TBL] [Abstract][Full Text] [Related]
3. Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase. Motyl J; Przykaza Ł; Boguszewski PM; Kosson P; Strosznajder JB Neuropharmacology; 2018 Jun; 135():139-150. PubMed ID: 29481916 [TBL] [Abstract][Full Text] [Related]
4. Effect of Oleracein E, a Neuroprotective Tetrahydroisoquinoline, on Rotenone-Induced Parkinson's Disease Cell and Animal Models. Sun H; He X; Liu C; Li L; Zhou R; Jin T; Yue S; Feng D; Gong J; Sun J; Ji J; Xiang L ACS Chem Neurosci; 2017 Jan; 8(1):155-164. PubMed ID: 27731637 [TBL] [Abstract][Full Text] [Related]
5. FTY720 Attenuates 6-OHDA-Associated Dopaminergic Degeneration in Cellular and Mouse Parkinsonian Models. Ren M; Han M; Wei X; Guo Y; Shi H; Zhang X; Perez RG; Lou H Neurochem Res; 2017 Feb; 42(2):686-696. PubMed ID: 27943027 [TBL] [Abstract][Full Text] [Related]
6. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination. Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293 [TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase 1/sphingosine-1-phosphate receptors dependent signalling in neurodegenerative diseases. The promising target for neuroprotection in Parkinson's disease. Motyl J; Strosznajder JB Pharmacol Rep; 2018 Oct; 70(5):1010-1014. PubMed ID: 30138818 [TBL] [Abstract][Full Text] [Related]
8. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes. Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704 [TBL] [Abstract][Full Text] [Related]
9. Dissociation between the anti-allodynic effects of fingolimod (FTY720) and desensitization of S1P Pondelick AM; Moncayo LV; Donvito G; McLane VD; Gillespie JC; Hauser KF; Spiegel S; Lichtman AH; Sim-Selley LJ; Selley DE Neuropharmacology; 2024 Dec; 261():110165. PubMed ID: 39303855 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective Effects of Tanshinone I Against 6-OHDA-Induced Oxidative Stress in Cellular and Mouse Model of Parkinson's Disease Through Upregulating Nrf2. Jing X; Wei X; Ren M; Wang L; Zhang X; Lou H Neurochem Res; 2016 Apr; 41(4):779-86. PubMed ID: 26537816 [TBL] [Abstract][Full Text] [Related]
12. Differential Tolerance to FTY720-Induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of Sphingosine-1-Phosphate Receptor Adaptation. Sim-Selley LJ; Wilkerson JL; Burston JJ; Hauser KF; McLane V; Welch SP; Lichtman AH; Selley DE J Pharmacol Exp Ther; 2018 Sep; 366(3):509-518. PubMed ID: 29945931 [TBL] [Abstract][Full Text] [Related]
13. Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV. Geffin R; Martinez R; de Las Pozas A; Issac B; McCarthy M J Neurovirol; 2017 Dec; 23(6):808-824. PubMed ID: 28913617 [TBL] [Abstract][Full Text] [Related]
14. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease. Kopalli SR; Noh SJ; Koppula S; Suh YH Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419 [TBL] [Abstract][Full Text] [Related]
15. Chitosan nanocarrier for FTY720 enhanced delivery retards Parkinson's disease via PP2A-EzH2 signaling in vitro and ex vivo. Sardoiwala MN; Karmakar S; Choudhury SR Carbohydr Polym; 2021 Feb; 254():117435. PubMed ID: 33357908 [TBL] [Abstract][Full Text] [Related]
16. Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models. Maasz G; Zrinyi Z; Reglodi D; Petrovics D; Rivnyak A; Kiss T; Jungling A; Tamas A; Pirger Z Dis Model Mech; 2017 Feb; 10(2):127-139. PubMed ID: 28067625 [TBL] [Abstract][Full Text] [Related]
17. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation. Tsai HC; Huang Y; Garris CS; Moreno MA; Griffin CW; Han MH JCI Insight; 2016 Jun; 1(9):e86462. PubMed ID: 27699272 [TBL] [Abstract][Full Text] [Related]
18. Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway. Li Q; Li S; Fang J; Yang C; Zhao X; Wang Q; Zhou W; Zheng W Molecules; 2023 Jul; 28(14):. PubMed ID: 37513399 [TBL] [Abstract][Full Text] [Related]
19. Modulation of sphingosine-1-phosphate receptor ameliorates harmaline-induced essential tremor in rat. Dahmardeh N; Asadi-Shekaari M; Arjmand S; Kalantaripour T; Basiri M; Shabani M Neurosci Lett; 2017 Jul; 653():376-381. PubMed ID: 28627375 [TBL] [Abstract][Full Text] [Related]
20. Humulus japonicus Prevents Dopaminergic Neuron Death in 6-Hydroxydopamine-Induced Models of Parkinson's Disease. Ryu YK; Kang Y; Go J; Park HY; Noh JR; Kim YH; Hwang JH; Choi DH; Han SS; Oh WK; Lee CH; Kim KS J Med Food; 2017 Feb; 20(2):116-123. PubMed ID: 28146406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]